Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-48.76	-418.05	815.92
Graham Fair Price	27.59	13.84	10.84
PEG	-52.60	0.25	-0.52
Price/Book	-3.01	0.70	0.72
Price/Cash Flow	730.56	49.83	6.00
Prices/Earnings	-40.13	15.55	25.97
Price/Sales	-8.11	6.61	7.19
Price/FCF	730.56	49.83	6.00
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-11.62	0.88	1.00
Operating Margin	21.48	0.14	0.12
ROA	61.71	< 0.005	< 0.005
ROE	< 0.005	0.01	62.00
ROIC	0.01	< 0.005	-8.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.18	85.32
Dividends QOQ	< 0.005	0.05	1297.18
EBIT QOQ	-0.28	0.29	3.90
EPS QOQ	-0.50	0.63	26.32
FCF QOQ	9.94	-0.88	-91.11
Revenue QOQ	0.75	0.06	-92.06
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-1537.12	-100.00
Days Sales Outstanding (DSO)	31.91	30.21	-5.34
Inventory Turnover	0.00	-0.06	-100.00
Debt/Capitalization	0.29	0.28	-5.23
Quick Ratio	0.80	0.78	-2.26
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	27.37	27.44	0.24
Cash	30.09	28.97	-3.71
Capex	-0.05	-0.08	-50.62
Free Cash Flow	3.31	0.39	-88.29
Revenue	2.76	2.92	5.81
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.15	0.15	-0.25
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	197.33	-100.58	-49.03
Naive Interpretation	Member

06 - Financial Health · Bad

Rating